More about our research expertise and experience
At PRC: Blackpool, we have extensive research experience which is evidenced in the results that we deliver.
Research Expertise
Our expertise in commercial research spans a wide range of clinical specialties, including cardiology, haematology, oncology, gastroenterology and respiratory disease. We have over 40 experienced Principal Investigators undertaking research in more than 20 different therapeutic areas and chief investigators leading research in cardiology, cardiothoracic, gastroenterology, orthopaedics, infectious diseases.
Track record
At PRC: Blackpool we have a strong track record of initiating and recruiting to our trials at pace and within timelines. We have increased our commercial study support by 40% in 2020/21 compared to previous years. In line with this, we have expedited set-up of our trials which has resulted in our PRC being the first UK/EU site to open three late phase oncology and one haematology trial in the past six months. This has provided a rapid start up for our industry partners, allowing our patients to receive new treatment options as soon as possible. Our industry partners have been impressed with our streamlined set-up processes confirming PRC: Blackpool had one of the fastest set-up times since 2017 according to key sponsor metrics.
Recruitment Successes
At PRC: Blackpool we understand the importance of supporting the life sciences industry to deliver research within the NHS. We have consistently achieved excellent late-phase commercial research time and target figures with average rates of 79% over the past three years. This has led to repeat business and year-on-year increases in both commercial and non-commercial studies being awarded to our host Blackpool Teaching Hospitals NHS Foundation Trust with a 30% increase in patient recruitment for commercial trials from 2019/20 to 2020/21. To date we have worked with a number of pharmaceutical companies and Contract Research Organisations including Bayer, Roche, Novartis, Sanofi, Astrazeneca, GSK, Janssen, Pfizer, Lilly, Amgen and with Syneos, IQVIA and Paraexel.
Successes include:
- First Global Recruit for the Phase III NOVAVAX COVID-19 Vaccine Trial in partnership with Faylde Coast Clinical Research.
- Recruiting above targets to both the NOVAVAX and VALNEVA COVID-19 vaccine trials within the recruitment window.
- Two UK first participant to Phase III oncology trials.
- Two UK first participant to Phase III haematology trials.
Get in touch
- Telephone : 01253 951514
- Email : bfwh.prc.blackpool@nhs.net.